stroke and brain injury, Completed Research

Safety, Efficacy and Tolerability of BAF312

August 17, 2023

< 1

Safety, Efficacy and Tolerability of BAF312 in Patients with Stroke due to Intracerebral Hemorrhage

A double blind, randomized, placebo-controlled phase II trial for Novartis (siponimod) in patients with intracerebral hemorrhage

Project Type: Research

Year started: 2021

Diagnosis: Stroke

Does Bioness Integrated Therapy System (BITS) Touch Screen Technology Improve Field Awareness to...

Read details

Insulin Resistance Intervention after Stroke Trial (IRIS): A StrokeNet Study The Insulin...

Read details

RISE-UP Study/Sleep SMART Trials This trial is designed to test whether treatment of obstructive...

Read details